Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 1
1946 2
1948 3
1950 1
1951 1
1952 1
1953 2
1956 4
1957 1
1963 2
1965 1
1967 3
1969 6
1970 1
1971 5
1972 2
1974 2
1975 4
1976 3
1977 2
1978 6
1979 5
1980 3
1981 3
1982 5
1983 1
1984 4
1985 3
1986 11
1987 4
1988 10
1989 7
1990 11
1991 23
1992 20
1993 23
1994 21
1995 18
1996 13
1997 23
1998 22
1999 27
2000 25
2001 21
2002 15
2003 33
2004 30
2005 40
2006 39
2007 28
2008 51
2009 42
2010 46
2011 49
2012 43
2013 52
2014 53
2015 62
2016 45
2017 55
2018 72
2019 61
2020 64
2021 64
2022 58
2023 48
2024 50
2025 71
2026 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,384 results

Results by year

Filters applied: . Clear all
Page 1
Humoral determinants of checkpoint immunotherapy.
Dai Y, Aizenbud L, Qin K, Austin M, Jaycox JR, Cunningham J, Wang EY, Zhang L, Fischer S, Carroll SM, van Aggelen H, Kluger Y, Herold KC, Furchtgott L, Kluger HM, Ring AM. Dai Y, et al. Among authors: austin m. Nature. 2025 Aug;644(8076):527-536. doi: 10.1038/s41586-025-09188-4. Epub 2025 Jul 23. Nature. 2025. PMID: 40702172
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.
Othman J, Tiong IS, O'Nions J, Dennis M, Mokretar K, Ivey A, Austin M, Latif AL, Amer M, Chan WY, Crawley C, Crolla F, Cross J, Dang R, Elliot J, Fong CY, Galli S, Gallipoli P, Hogan F, Kalkur P, Khan A, Krishnamurthy P, Laurie J, Loo S, Marshall S, Mehta P, Murthy V, Nagumantry S, Pillai S, Potter N, Sellar R, Taylor T, Zhao R, Russell NH, Wei AH, Dillon R. Othman J, et al. Among authors: austin m. Blood. 2024 Jan 25;143(4):336-341. doi: 10.1182/blood.2023021579. Blood. 2024. PMID: 37647641 Free article.
Update on neuroblastoma.
Newman EA, Abdessalam S, Aldrink JH, Austin M, Heaton TE, Bruny J, Ehrlich P, Dasgupta R, Baertschiger RM, Lautz TB, Rhee DS, Langham MR Jr, Malek MM, Meyers RL, Nathan JD, Weil BR, Polites S, Madonna MB; APSA Cancer committee. Newman EA, et al. Among authors: austin m. J Pediatr Surg. 2019 Mar;54(3):383-389. doi: 10.1016/j.jpedsurg.2018.09.004. Epub 2018 Sep 19. J Pediatr Surg. 2019. PMID: 30305231 Review.
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group.
Sargen MR, Barnhill RL, Elder DE, Swetter SM, Prieto VG, Ko JS, Bahrami A, Gerami P, Karunamurthy A, Pappo AS, Schuchter LM, LeBoit PE, Yeh I, Kirkwood JM, Jen M, Dunkel IJ, Durham MM, Christison-Lagay ER, Austin MT, Aldrink JH, Mehrhoff C, Hawryluk EB, Chu EY, Busam KJ, Sondak V, Messina J, Puig S, Colebatch AJ, Coughlin CC, Berrebi KG, Laetsch TW, Mitchell SG, Seynnaeve B. Sargen MR, et al. Among authors: austin mt. J Clin Oncol. 2025 Mar 20;43(9):1157-1167. doi: 10.1200/JCO.24.01154. Epub 2024 Oct 4. J Clin Oncol. 2025. PMID: 39365959 Free PMC article.
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.
Weiss SA, Djureinovic D, Wei W, Tran T, Austin M, Markowitz J, Eroglu Z, Khushalani NI, Hegde U, Cohen J, Sznol M, Anderson G, Johnson B, Piteo C, Mahajan A, Adeniran A, Jilaveanu L, Goldberg S, Chiang V, Forsyth P, Kluger HM. Weiss SA, et al. Among authors: austin m. J Clin Oncol. 2025 May 10;43(14):1685-1694. doi: 10.1200/JCO-24-02219. Epub 2025 Mar 6. J Clin Oncol. 2025. PMID: 40048689 Free PMC article. Clinical Trial.
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS.
Othman J, Lam HPJ, Leong S, Basheer F, Abdallah I, Fleming K, Mehta P, Yassin H, Laurie J, Austin M, Gallipoli P, Taylor T, Dennis M, Elliot J, Clarke G, Dang R, Vidler J, Krishnamurthy P, Latif AL, Kalkur P, Shahidianakbar M, Campbell V, Mannari D, Sutherland E, Wickramaratne T, Collins A, Zhao R, Mak H, Belsham E, Banerjee S, Bashir J, Pillai S, Whitmill R, Galli S, Amer M, Murthy V, Murray D, Wandroo F, Hogan F, Crolla F, Fowler N, Khan A, O'Nions J, Dillon R. Othman J, et al. Among authors: austin m. Blood Neoplasia. 2024 May 23;1(3):100017. doi: 10.1016/j.bneo.2024.100017. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40453057 Free PMC article. Clinical Trial.
2025 ICM: Antibiotic Prophylaxis.
Shahi A, Luo TD, Yayac M, Jennings JM, Salles MJ, Saka N, Srirangarajan T, Nelson R, Christopher ZK, Aguilera SP, Austin MS, Barton KI, Bartosz P, Benito N, Braun S, Damioli LE, da Silva RB, Devito FS, Dos Santos EC, Duran MV, Papagelopoulos PJ, Enviado N, Figueroa D, Garcia-Bógalo R, Giori NJ, Guild G, Hammad AS, Honda H, Honkanen M, Hoveidaei AH, Kandel C, Kendrick B, Klaber I, Konen T, Lee GC, Li B, Marín-Peña Ó, Mathis K, Megaloikonomos PD, Mitt P, Molloy JR, Morikane K, Parvizi J, Peel TN, Pelt CE, Ramírez D, Schweitzer D, Seriacopi LS, Silibovsky R, Stucinskas J, Tillander J, Uchiyama K, Uçkay I, Vasarhelyi EM, Vigante D, Yamada K, Yan CH, Yildiz F. Shahi A, et al. Among authors: austin ms. J Arthroplasty. 2025 Dec;41(1S1):S30-S52. doi: 10.1016/j.arth.2025.10.087. Epub 2025 Oct 30. J Arthroplasty. 2025. PMID: 41176125 No abstract available.
Canadian Stroke Best Practice Recommendations: Vascular cognitive impairment, 7th edition practice guidelines update, 2024.
Swartz RH, Longman RS, Lindsay MP, Lund R, Ganesh A, Eskes GA, Austin M, Bechard LE, Bhangu J, Bruto VC, Carter S, Chow N, Deschaintre Y, Fedorchuk K, Fellows L, Foley N, Greer LA, Lee DS, Leonard C, Patel R, Poonyania S, Poulin V, Quraishi F, Roach P, Shoniker T, Tuchak C, Mountain A, Martin C, Smith EE; Canadian Stroke Best Practice Recommendations Advisory Committee, in collaboration with the Canadian Stroke Consortium, Canadian Neurological Sciences Federation, and CanStroke Recovery Trials Platform. Swartz RH, et al. Among authors: austin m. Alzheimers Dement. 2025 Jan;21(1):e14324. doi: 10.1002/alz.14324. Epub 2025 Jan 16. Alzheimers Dement. 2025. PMID: 39822128 Free PMC article.
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation.
Dembitz V, Lawson H, Burt R, Natani S, Philippe C, James SC, Atkinson S, Durko J, Wang LM, Campos J, Magee AMS, Woodley K, Austin MJ, Rio-Machin A, Casado P, Bewicke-Copley F, Rodriguez Blanco G, Pereira-Martins D, Oudejans L, Boet E, von Kriegsheim A, Schwaller J, Finch AJ, Patel B, Sarry JE, Tamburini J, Schuringa JJ, Hazlehurst L, Copland Iii JA, Yuneva M, Peck B, Cutillas P, Fitzgibbon J, Rouault-Pierre K, Kranc K, Gallipoli P. Dembitz V, et al. Among authors: austin mj. Leukemia. 2024 Nov;38(11):2395-2409. doi: 10.1038/s41375-024-02390-9. Epub 2024 Aug 26. Leukemia. 2024. PMID: 39187579 Free PMC article.
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
Di Mambro A, Arroyo-Berdugo Y, Fioretti T, Randles M, Cozzuto L, Rajeeve V, Cevenini A, Austin MJ, Esposito G, Ponomarenko J, Lucas CM, Cutillas P, Gribben J, Williams O, Calle Y, Patel B, Esposito MT. Di Mambro A, et al. Among authors: austin mj. Oncogene. 2023 Dec;42(50):3670-3683. doi: 10.1038/s41388-023-02840-1. Epub 2023 Oct 27. Oncogene. 2023. PMID: 37891368 Free PMC article.
1,384 results